 | • レポートコード：20QY06-08187 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、皮膚科OTC薬のグローバル市場について種類別（外用、経口）、用途別（病院、ドラッグストア、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・皮膚科OTC薬市場の概要 ・世界の主要地域別皮膚科OTC薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の皮膚科OTC薬市場規模2015-2026：種類別（外用、経口） ・世界の皮膚科OTC薬市場規模2015-2026：用途別（病院、ドラッグストア、その他） ・皮膚科OTC薬の北米市場規模2015-2020 ・皮膚科OTC薬のヨーロッパ市場規模2015-2020 ・皮膚科OTC薬の中国市場規模2015-2020 ・皮膚科OTC薬の日本市場規模2015-2020 ・皮膚科OTC薬の東南アジア市場規模2015-2020 ・皮膚科OTC薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Bayer、GSK、Teva、Johnson & Johnson、Novartis、Mylan、Sun Pharmaceutical、Aurobindo、Galderma、CR SANJIU、Dr. Reddy's、Lupin、Bausch Health、Cipla、Qilu Pharmaceutical、Almirall、Lingrui） ・皮膚科OTC薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・皮膚科OTC薬の市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Dermatology OTC Medications Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Dermatology OTC Medications market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Dermatology drug is used in the management and treatment of diseases related to skin. Acne, psoriasis, and dermatitis are some common skin diseases. Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Dermatology OTC Medications market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Dermatology OTC Medications industry.
Based on our recent survey, we have several different scenarios about the Dermatology OTC Medications YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 12000 million in 2019. The market size of Dermatology OTC Medications will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Dermatology OTC Medications market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Dermatology OTC Medications market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Dermatology OTC Medications market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Dermatology OTC Medications market. The report also includes nautical information, where it shows Dermatology OTC Medications market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Dermatology OTC Medications market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Dermatology OTC Medications market.
Market competition is intense. Bayer, GSK, Teva, Johnson & Johnson, Novartis, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. Top 5 manufacturers accounted for 25.08% market share in 2019.
Geographical Analysis:
Based on region, the global Dermatology OTC Medications market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Dermatology OTC Medications market are
Bayer
GSK
Teva
Johnson & Johnson
Novartis
Mylan
Sun Pharmaceutical
Aurobindo
Galderma
CR SANJIU
Dr. Reddy’s
Lupin
Bausch Health
Cipla
Qilu Pharmaceutical
Almirall
Lingrui
Segment by Type
External Use
Oral
The classification of dermatology OTC medications includes external use, oral and the proportion of external use in 2019 is about 93%.
Segment by Application
Hospital
Drug Store
Other
Dermatology OTC medications is widely used in hospital, drug store and other field. The most proportion of dermatology OTC medications is drug store, and the proportion in 2019 is 58.2%.
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Dermatology OTC Medications market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Dermatology OTC Medications market.
• The market share of the global Dermatology OTC Medications market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Dermatology OTC Medications market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Dermatology OTC Medications market.
1 Dermatology OTC Medications Market Overview
1.1 Dermatology OTC Medications Product Scope
1.2 Dermatology OTC Medications Segment by Type
1.2.1 Global Dermatology OTC Medications Sales by Type (2020-2026)
1.2.2 External Use
1.2.3 Oral
1.3 Dermatology OTC Medications Segment by Application
1.3.1 Global Dermatology OTC Medications Sales Comparison by Application (2020-2026)
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Other
1.4 Dermatology OTC Medications Market Estimates and Forecasts (2015-2026)
1.4.1 Global Dermatology OTC Medications Sales Growth Rate (2015-2026)
1.4.2 Global Dermatology OTC Medications Revenue and Growth Rate (2015-2026)
1.4.3 Global Dermatology OTC Medications Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Dermatology OTC Medications Industry Impact
1.5.1 How the Covid-19 is Affecting the Dermatology OTC Medications Industry
1.5.1.1 Dermatology OTC Medications Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Dermatology OTC Medications Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Dermatology OTC Medications Players to Combat Covid-19 Impact
2 Dermatology OTC Medications Estimate and Forecast by Region
2.1 Global Dermatology OTC Medications Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Dermatology OTC Medications Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Dermatology OTC Medications Sales Market Share by Region (2015-2020)
2.2.2 Global Dermatology OTC Medications Revenue Market Share by Region (2015-2020)
2.3 Global Dermatology OTC Medications Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Dermatology OTC Medications Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Dermatology OTC Medications Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Dermatology OTC Medications Estimates and Projections (2015-2026)
2.4.2 Europe Dermatology OTC Medications Estimates and Projections (2015-2026)
2.4.3 China Dermatology OTC Medications Estimates and Projections (2015-2026)
2.4.4 Japan Dermatology OTC Medications Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Dermatology OTC Medications Estimates and Projections (2015-2026)
2.4.6 India Dermatology OTC Medications Estimates and Projections (2015-2026)
3 Global Dermatology OTC Medications Competition Landscape by Players
3.1 Global Top Dermatology OTC Medications Players by Sales (2015-2020)
3.2 Global Top Dermatology OTC Medications Players by Revenue (2015-2020)
3.3 Global Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology OTC Medications as of 2019)
3.4 Global Dermatology OTC Medications Average Price by Company (2015-2020)
3.5 Manufacturers Dermatology OTC Medications Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Dermatology OTC Medications Players (Opinion Leaders)
4 Global Dermatology OTC Medications Market Size by Type
4.1 Global Dermatology OTC Medications Historic Market Review by Type (2015-2020)
4.1.1 Global Dermatology OTC Medications Sales Market Share by Type (2015-2020)
4.1.2 Global Dermatology OTC Medications Revenue Market Share by Type (2015-2020)
4.1.3 Global Dermatology OTC Medications Price by Type (2014-2020)
4.2 Global Dermatology OTC Medications Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Dermatology OTC Medications Sales Forecast by Type (2021-2026)
4.2.2 Global Dermatology OTC Medications Revenue Forecast by Type (2021-2026)
4.2.3 Global Dermatology OTC Medications Price Forecast by Type (2021-2026)
5 Global Dermatology OTC Medications Market Size by Application
5.1 Global Dermatology OTC Medications Historic Market Review by Application (2015-2020)
5.1.1 Global Dermatology OTC Medications Sales Market Share by Application (2015-2020)
5.1.2 Global Dermatology OTC Medications Revenue Market Share by Application (2015-2020)
5.1.3 Global Dermatology OTC Medications Price by Application (2015-2020)
5.2 Global Dermatology OTC Medications Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Dermatology OTC Medications Sales Forecast by Application (2021-2026)
5.2.2 Global Dermatology OTC Medications Revenue Forecast by Application (2021-2026)
5.2.3 Global Dermatology OTC Medications Price Forecast by Application (2021-2026)
3 North America Dermatology OTC Medications Market Facts & Figures
3.2 North America Dermatology OTC Medications Sales Market Share by Company (2015-2020)
3.3 North America Dermatology OTC Medications Sales Market Share by Type (2015-2020)
3.4 North America Dermatology OTC Medications Sales Market Share by Application (2015-2020)
4 Europe Dermatology OTC Medications Market Facts & Figures
4.2 Europe Dermatology OTC Medications Sales Market Share by Company (2015-2020)
4.3 Europe Dermatology OTC Medications Sales Market Share by Type (2015-2020)
4.4 Europe Dermatology OTC Medications Sales Market Share by Application (2015-2020)
5 China Dermatology OTC Medications Market Facts & Figures
5.2 China Dermatology OTC Medications Sales Market Share by Company (2015-2020)
5.3 China Dermatology OTC Medications Sales Market Share by Type (2015-2020)
5.4 China Dermatology OTC Medications Sales Market Share by Application (2015-2020)
6 Japan Dermatology OTC Medications Market Facts & Figures
6.2 Japan Dermatology OTC Medications Sales Market Share by Company (2015-2020)
6.3 Japan Dermatology OTC Medications Sales Market Share by Type (2015-2020)
6.4 Japan Dermatology OTC Medications Sales Market Share by Application (2015-2020)
7 Southeast Asia Dermatology OTC Medications Market Facts & Figures
7.2 Southeast Asia Dermatology OTC Medications Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Dermatology OTC Medications Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Dermatology OTC Medications Sales Market Share by Application (2015-2020)
8 India Dermatology OTC Medications Market Facts & Figures
8.2 India Dermatology OTC Medications Sales Market Share by Company (2015-2020)
8.3 India Dermatology OTC Medications Sales Market Share by Type (2015-2020)
8.4 India Dermatology OTC Medications Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Dermatology OTC Medications Business
12.1 Bayer
12.1.1 Bayer Dermatology OTC Medications Corporation Information
12.1.2 Bayer Dermatology OTC Medications Business Overview and Total Revenue
12.1.3 Bayer Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer Dermatology OTC Medications Products Offered
12.1.5 Bayer Recent Development
12.2 GSK
12.2.1 GSK Dermatology OTC Medications Corporation Information
12.2.2 GSK Dermatology OTC Medications Business Overview and Total Revenue
12.2.3 GSK Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.2.4 GSK Dermatology OTC Medications Products Offered
12.2.5 GSK Recent Development
12.3 Teva
12.3.1 Teva Dermatology OTC Medications Corporation Information
12.3.2 Teva Dermatology OTC Medications Business Overview and Total Revenue
12.3.3 Teva Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Teva Dermatology OTC Medications Products Offered
12.3.5 Teva Recent Development
12.4 Johnson & Johnson
12.4.1 Johnson & Johnson Dermatology OTC Medications Corporation Information
12.4.2 Johnson & Johnson Dermatology OTC Medications Business Overview and Total Revenue
12.4.3 Johnson & Johnson Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Johnson & Johnson Dermatology OTC Medications Products Offered
12.4.5 Johnson & Johnson Recent Development
12.5 Novartis
12.5.1 Novartis Dermatology OTC Medications Corporation Information
12.5.2 Novartis Dermatology OTC Medications Business Overview and Total Revenue
12.5.3 Novartis Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Novartis Dermatology OTC Medications Products Offered
12.5.5 Novartis Recent Development
12.6 Mylan
12.6.1 Mylan Dermatology OTC Medications Corporation Information
12.6.2 Mylan Dermatology OTC Medications Business Overview and Total Revenue
12.6.3 Mylan Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Mylan Dermatology OTC Medications Products Offered
12.6.5 Mylan Recent Development
12.7 Sun Pharmaceutical
12.7.1 Sun Pharmaceutical Dermatology OTC Medications Corporation Information
12.7.2 Sun Pharmaceutical Dermatology OTC Medications Business Overview and Total Revenue
12.7.3 Sun Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Sun Pharmaceutical Dermatology OTC Medications Products Offered
12.7.5 Sun Pharmaceutical Recent Development
12.8 Aurobindo
12.8.1 Aurobindo Dermatology OTC Medications Corporation Information
12.8.2 Aurobindo Dermatology OTC Medications Business Overview and Total Revenue
12.8.3 Aurobindo Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Aurobindo Dermatology OTC Medications Products Offered
12.8.5 Aurobindo Recent Development
12.9 Galderma
12.9.1 Galderma Dermatology OTC Medications Corporation Information
12.9.2 Galderma Dermatology OTC Medications Business Overview and Total Revenue
12.9.3 Galderma Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Galderma Dermatology OTC Medications Products Offered
12.9.5 Galderma Recent Development
12.10 CR SANJIU
12.10.1 CR SANJIU Dermatology OTC Medications Corporation Information
12.10.2 CR SANJIU Dermatology OTC Medications Business Overview and Total Revenue
12.10.3 CR SANJIU Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.10.4 CR SANJIU Dermatology OTC Medications Products Offered
12.10.5 CR SANJIU Recent Development
12.11 Dr. Reddy’s
12.11.1 Dr. Reddy’s Dermatology OTC Medications Corporation Information
12.11.2 Dr. Reddy’s Dermatology OTC Medications Business Overview and Total Revenue
12.11.3 Dr. Reddy’s Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Dr. Reddy’s Dermatology OTC Medications Products Offered
12.11.5 Dr. Reddy’s Recent Development
12.12 Lupin
12.12.1 Lupin Dermatology OTC Medications Corporation Information
12.12.2 Lupin Dermatology OTC Medications Business Overview and Total Revenue
12.12.3 Lupin Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Lupin Dermatology OTC Medications Products Offered
12.12.5 Lupin Recent Development
12.13 Bausch Health
12.13.1 Bausch Health Dermatology OTC Medications Corporation Information
12.13.2 Bausch Health Dermatology OTC Medications Business Overview and Total Revenue
12.13.3 Bausch Health Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Bausch Health Dermatology OTC Medications Products Offered
12.13.5 Bausch Health Recent Development
12.14 Cipla
12.14.1 Cipla Dermatology OTC Medications Corporation Information
12.14.2 Cipla Dermatology OTC Medications Business Overview and Total Revenue
12.14.3 Cipla Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Cipla Dermatology OTC Medications Products Offered
12.14.5 Cipla Recent Development
12.15 Qilu Pharmaceutical
12.15.1 Qilu Pharmaceutical Dermatology OTC Medications Corporation Information
12.15.2 Qilu Pharmaceutical Dermatology OTC Medications Business Overview and Total Revenue
12.15.3 Qilu Pharmaceutical Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Qilu Pharmaceutical Dermatology OTC Medications Products Offered
12.15.5 Qilu Pharmaceutical Recent Development
12.16 Almirall
12.16.1 Almirall Dermatology OTC Medications Corporation Information
12.16.2 Almirall Dermatology OTC Medications Business Overview and Total Revenue
12.16.3 Almirall Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Almirall Dermatology OTC Medications Products Offered
12.16.5 Almirall Recent Development
12.17 Lingrui
12.17.1 Lingrui Dermatology OTC Medications Corporation Information
12.17.2 Lingrui Dermatology OTC Medications Business Overview and Total Revenue
12.17.3 Lingrui Dermatology OTC Medications Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Lingrui Dermatology OTC Medications Products Offered
12.17.5 Lingrui Recent Development
13 Dermatology OTC Medications Manufacturing Cost Analysis
13.1 Dermatology OTC Medications Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Dermatology OTC Medications
13.4 Dermatology OTC Medications Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Dermatology OTC Medications Distributors List
14.3 Dermatology OTC Medications Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Dermatology OTC Medications Sales (M Units) Growth Rate by Type (2020-2026)
Table 2. Global Dermatology OTC Medications Sales (M Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Dermatology OTC Medications Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Dermatology OTC Medications Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Dermatology OTC Medications Players to Combat Covid-19 Impact
Table 8. Global Market Dermatology OTC Medications Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Dermatology OTC Medications Sales (M Units) by Region (2015-2020)
Table 10. Global Dermatology OTC Medications Sales Market Share by Region (2015-2020)
Table 11. Global Dermatology OTC Medications Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Dermatology OTC Medications Revenue Share by Region (2015-2020)
Table 13. Global Dermatology OTC Medications Sales (M Units) Forecast by Region (2021-2026)
Table 14. Global Dermatology OTC Medications Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Dermatology OTC Medications Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Dermatology OTC Medications Revenue Share Forecast by Region (2021-2026)
Table 17. Global Dermatology OTC Medications (M Units) of Key Companies (2015-2020)
Table 18. Global Dermatology OTC Medications Sales Share by Company (2015-2020)
Table 19. Global Dermatology OTC Medications Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Dermatology OTC Medications Revenue Share by Company (2015-2020)
Table 21. Global Dermatology OTC Medications by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dermatology OTC Medications as of 2019)
Table 22. Global Dermatology OTC Medications Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Dermatology OTC Medications Manufacturing Sites and Area Served
Table 24. Manufacturers Dermatology OTC Medications Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Dermatology OTC Medications Players
Table 27. Global Dermatology OTC Medications Sales (M Units) by Type (2015-2020)
Table 28. Global Dermatology OTC Medications Sales Share by Type (2015-2020)
Table 29. Global Dermatology OTC Medications Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Dermatology OTC Medications Price (M Units) by Type (2015-2020)
Table 31. Global Dermatology OTC Medications Sales Share by Type (2021-2026)
Table 32. Global Dermatology OTC Medications Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Dermatology OTC Medications Revenue Share by Type (2021-2026)
Table 34. Global Dermatology OTC Medications Price (M Units) by Type (2021-2026)
Table 35. Global Dermatology OTC Medications Sales (M Units) by Application (2015-2020)
Table 36. Global Dermatology OTC Medications Sales Share by Application (2015-2020)
Table 37. Global Dermatology OTC Medications Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Dermatology OTC Medications Price (M Units) by Application (2015-2020)
Table 39. Global Dermatology OTC Medications Sales (M Units) by Application (2021-2026)
Table 40. Global Dermatology OTC Medications Sales Share by Application (2021-2026)
Table 41. Global Dermatology OTC Medications Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Dermatology OTC Medications Revenue Share by Application (2021-2026)
Table 43. Global Dermatology OTC Medications Price (M Units) by Application (2021-2026)
Table 44. United States Dermatology OTC Medications Sales (M Units) by Company (2015-2020)
Table 45. United States Dermatology OTC Medications Sales Market Share by Company (2015-2020)
Table 46. United States Dermatology OTC Medications Sales (M Units) by Type (2015-2020)
Table 47. United States Dermatology OTC Medications Sales Market Share by Type (2015-2020)
Table 48. United States Dermatology OTC Medications Sales (M Units) by Application (2015-2020)
Table 49. United States Dermatology OTC Medications Sales Market Share by Application (2015-2020)
Table 50. Europe Dermatology OTC Medications Sales (M Units) by Company (2015-2020)
Table 51. Europe Dermatology OTC Medications Sales Market Share by Company (2015-2020)
Table 52. Europe Dermatology OTC Medications Sales (M Units) by Type (2015-2020)
Table 53. Europe Dermatology OTC Medications Sales Market Share by Type (2015-2020)
Table 54. Europe Dermatology OTC Medications Sales (M Units) by Application (2015-2020)
Table 55. Europe Dermatology OTC Medications Sales Market Share by Type (2015-2020)
Table 56. China Dermatology OTC Medications Sales (M Units) by Company (2015-2020)
Table 57. China Dermatology OTC Medications Sales Market Share by Company (2015-2020)
Table 58. China Dermatology OTC Medications Sales (M Units) by Type (2015-2020)
Table 59. China Dermatology OTC Medications Sales Market Share by Type (2015-2020)
Table 60. China Dermatology OTC Medications Sales (M Units) by Application (2015-2020)
Table 61. China Dermatology OTC Medications Sales Market Share by Application (2015-2020)
Table 62. Japan Dermatology OTC Medications Sales (M Units) by Company (2015-2020)
Table 63. Japan Dermatology OTC Medications Sales Market Share by Company (2015-2020)
Table 64. Japan Dermatology OTC Medications Sales (M Units) by Type (2015-2020)
Table 65. Japan Dermatology OTC Medications Sales Market Share by Type (2015-2020)
Table 66. Japan Dermatology OTC Medications Sales (M Units) by Application (2015-2020)
Table 67. Japan Dermatology OTC Medications Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Dermatology OTC Medications Sales (M Units) by Company (2015-2020)
Table 69. Southeast Asia Dermatology OTC Medications Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Dermatology OTC Medications Sales (M Units) by Type (2015-2020)
Table 71. Southeast Asia Dermatology OTC Medications Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Dermatology OTC Medications Sales (M Units) by Type (2015-2020)
Table 73. Southeast Asia Dermatology OTC Medications Sales Market Share by Application (2015-2020)
Table 74. India Dermatology OTC Medications Sales (M Units) by Company (2015-2020)
Table 75. India Dermatology OTC Medications Sales Market Share by Company (2015-2020)
Table 76. India Dermatology OTC Medications Sales (M Units) by Type (2015-2020)
Table 77. India Dermatology OTC Medications Sales Market Share by Type (2015-2020)
Table 78. India Dermatology OTC Medications Sales (M Units) by Application (2015-2020)
Table 79. India Dermatology OTC Medications Sales Market Share by Application (2015-2020)
Table 80. Bayer Corporation Information
Table 81. Bayer Description and Business Overview
Table 82. Bayer Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Bayer Dermatology OTC Medications Product
Table 84. Bayer Recent Development
Table 85. GSK Corporation Information
Table 86. GSK Description and Business Overview
Table 87. GSK Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. GSK Dermatology OTC Medications Product
Table 89. GSK Recent Development
Table 90. Teva Corporation Information
Table 91. Teva Description and Business Overview
Table 92. Teva Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Teva Dermatology OTC Medications Product
Table 94. Teva Recent Development
Table 95. Johnson & Johnson Corporation Information
Table 96. Johnson & Johnson Description and Business Overview
Table 97. Johnson & Johnson Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Johnson & Johnson Dermatology OTC Medications Product
Table 99. Johnson & Johnson Recent Development
Table 100. Novartis Corporation Information
Table 101. Novartis Description and Business Overview
Table 102. Novartis Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Novartis Dermatology OTC Medications Product
Table 104. Novartis Recent Development
Table 105. Mylan Corporation Information
Table 106. Mylan Description and Business Overview
Table 107. Mylan Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Mylan Dermatology OTC Medications Product
Table 109. Mylan Recent Development
Table 110. Sun Pharmaceutical Corporation Information
Table 111. Sun Pharmaceutical Description and Business Overview
Table 112. Sun Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Sun Pharmaceutical Dermatology OTC Medications Product
Table 114. Sun Pharmaceutical Recent Development
Table 115. Aurobindo Corporation Information
Table 116. Aurobindo Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Aurobindo Description and Business Overview
Table 118. Aurobindo Dermatology OTC Medications Product
Table 119. Aurobindo Recent Development
Table 120. Galderma Corporation Information
Table 121. Galderma Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Galderma Description and Business Overview
Table 123. Galderma Dermatology OTC Medications Product
Table 124. Galderma Recent Development
Table 125. CR SANJIU Corporation Information
Table 126. CR SANJIU Description and Business Overview
Table 127. CR SANJIU Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. CR SANJIU Dermatology OTC Medications Product
Table 129. CR SANJIU Recent Development
Table 130. Dr. Reddy's Corporation Information
Table 131. Dr. Reddy's Description and Business Overview
Table 132. Dr. Reddy's Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Dr. Reddy's Dermatology OTC Medications Product
Table 134. Dr. Reddy's Recent Development
Table 135. Lupin Corporation Information
Table 136. Lupin Description and Business Overview
Table 137. Lupin Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Lupin Dermatology OTC Medications Product
Table 139. Lupin Recent Development
Table 140. Bausch Health Corporation Information
Table 141. Bausch Health Description and Business Overview
Table 142. Bausch Health Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Bausch Health Dermatology OTC Medications Product
Table 144. Bausch Health Recent Development
Table 145. Cipla Corporation Information
Table 146. Cipla Description and Business Overview
Table 147. Cipla Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Cipla Dermatology OTC Medications Product
Table 149. Cipla Recent Development
Table 150. Qilu Pharmaceutical Corporation Information
Table 151. Qilu Pharmaceutical Description and Business Overview
Table 152. Qilu Pharmaceutical Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 153. Qilu Pharmaceutical Dermatology OTC Medications Product
Table 154. Qilu Pharmaceutical Recent Development
Table 155. Almirall Corporation Information
Table 156. Almirall Description and Business Overview
Table 157. Almirall Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 158. Almirall Dermatology OTC Medications Product
Table 159. Almirall Recent Development
Table . Lingrui Corporation Information
Table . Lingrui Description and Business Overview
Table . Lingrui Dermatology OTC Medications Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Lingrui Dermatology OTC Medications Product
Table . Lingrui Recent Development
Table 165. Production Base and Market Concentration Rate of Raw Material
Table 166. Key Suppliers of Raw Materials
Table 167. Dermatology OTC Medications Distributors List
Table 168. Dermatology OTC Medications Customers List
Table 169. Market Key Trends
Table 170. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 171. Key Challenges
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Dermatology OTC Medications Product Picture
Figure 2. Global Dermatology OTC Medications Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Dermatology OTC Medications Market Share by Application in 2020 & 2026
Figure 6. Hospital Examples
Figure 7. Drug Store Examples
Figure 8. Other Examples
Figure 9. Global Dermatology OTC Medications Sales (M Units) Growth Rate (2015-2026)
Figure 10. Global Dermatology OTC Medications Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Dermatology OTC Medications Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Dermatology OTC Medications Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Dermatology OTC Medications Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Dermatology OTC Medications Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Dermatology OTC Medications Sales (M Units) Growth Rate (2015-2026)
Figure 16. Europe Dermatology OTC Medications Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Dermatology OTC Medications Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Dermatology OTC Medications Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Dermatology OTC Medications Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Dermatology OTC Medications Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Dermatology OTC Medications Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Dermatology OTC Medications Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Dermatology OTC Medications Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Dermatology OTC Medications Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Dermatology OTC Medications Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Dermatology OTC Medications Players Market Share by Revenue in Dermatology OTC Medications 2015 & 2019
Figure 27. Dermatology OTC Medications Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Dermatology OTC Medications Revenue Share by Type (2015-2020)
Figure 29. Global Dermatology OTC Medications Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Dermatology OTC Medications Revenue Share by Application (2015-2020)
Figure 31. Global Dermatology OTC Medications Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Dermatology OTC Medications Sales Market Share by Type in 2019
Figure 33. United States Dermatology OTC Medications Sales Market Share by Type in 2019
Figure 34. Europe Dermatology OTC Medications Sales Market Share by Company in 2019
Figure 35. Europe Dermatology OTC Medications Sales Market Share by Type in 2019
Figure 36. Europe Dermatology OTC Medications Sales Market Share by Application in 2019
Figure 37. China Dermatology OTC Medications Sales Market Share by Company in 2019
Figure 38. China Dermatology OTC Medications Sales Market Share by Type in 2019
Figure 39. China Dermatology OTC Medications Sales Market Share by Application in 2019
Figure 40. Japan Dermatology OTC Medications Sales Market Share by Company in 2019
Figure 41. Japan Dermatology OTC Medications Sales Market Share by Type in 2019
Figure 42. Japan Dermatology OTC Medications Sales Market Share by Application in 2019
Figure 43. Southeast Asia Dermatology OTC Medications Sales Market Share by Company in 2019
Figure 44. Southeast Asia Dermatology OTC Medications Sales Market Share by Type in 2019
Figure 45. Southeast Asia Dermatology OTC Medications Sales Market Share by Application in 2019
Figure 46. India Dermatology OTC Medications Sales Market Share by Company in 2019
Figure 47. India Dermatology OTC Medications Sales Market Share by Type in 2019
Figure 48. India Dermatology OTC Medications Sales Market Share by Application in 2019
Figure 49. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Sun Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Aurobindo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Galderma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. CR SANJIU Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Dr. Reddy's Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Bausch Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Qilu Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Almirall Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Lingrui Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Key Raw Materials Price Trend
Figure 67. Manufacturing Cost Structure of Dermatology OTC Medications
Figure 68. Manufacturing Process Analysis of Dermatology OTC Medications
Figure 69. Dermatology OTC Medications Industrial Chain Analysis
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
Figure 72. Porter's Five Forces Analysis
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
皮膚科用OTC薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Dermatology OTC medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Dermatology OTC m…- 皮膚科薬の世界市場レポート2020 A recently published report by QY Research titled Global Dermatology Drug Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate d…
- 皮膚科レーザーの世界市場レポート2020 Market Analysis and Insights: Global Dermatology Lasers Market The global Dermatology Lasers market was valued at US$ 1895.6 million in 2019 and will reach US$ 4789.8 million by the end of 2026, growing at a CAGR of 14.0% during 2020-2026. Global Dermatology Lasers Scope and Market Size The global D…
- 皮膚科治療装置の世界市場レポート2020 Market Analysis and Insights: Global Dermatology Therapeutics Devices Market The global Dermatology Therapeutics Devices market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Dermatology Therapeutics Devices Sc…
- 緑内障治療薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Glaucoma Medications market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Glaucoma Medications mar…